Tag: Emory
Exclusive: Antibody against multiple emerging SARS-CoV-2 variants
A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants
Cipla signs COVID-19 drug licensing deal with MSD
Cipla enters into a licensing agreement with MSD to expand access to the investigational oral therapeutic drug for COVID-19 treatment...........................
COVID-19: ICGEB-Emory Vaccine Center’s fresh study offers hope to improve plasma therapy...
A new study by the ICGEB-Emory Vaccine Center offers hope to improve plasma therapy regimen in India..................